Reply to: "Non-selective beta blockers and mortality in decompensated cirrhosis: Is cirrhotic cardiomyopathy the missing link?"

J Hepatol. 2021 Oct;75(4):993-994. doi: 10.1016/j.jhep.2021.06.026. Epub 2021 Jul 2.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adrenergic beta-Antagonists
  • Cardiomyopathies*
  • Humans
  • Liver Cirrhosis* / complications
  • Liver Cirrhosis* / drug therapy

Substances

  • Adrenergic beta-Antagonists